Arkolith/Insider Trading/SIOX/Form 4

Nassif David W.

Chief Financial OfficerSio Gene Therapies Inc. (SIOX) · full profile →Form 4 · filed Dec 9, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2021Grant(A)18K—$052K
Dec 8, 2021Tax withholding(F)6K$1.42$9K45K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 8, 2021Disposed to issuer(D)18K—$035K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636050-21-000099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML